GSTM1 and Schnyder corneal dystrophy: In this study, we built a cohort simulation model to estimate how potential improvements in cognitive function (measured by IQ) through Hb-improving SCD treatment beginning in childhood can affect academic performance and achievement and educational attainment among patients with SCD in the United States.